These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 20208508)

  • 21. Modulation of peripheral serotonin levels by novel tryptophan hydroxylase inhibitors for the potential treatment of functional gastrointestinal disorders.
    Shi ZC; Devasagayaraj A; Gu K; Jin H; Marinelli B; Samala L; Scott S; Stouch T; Tunoori A; Wang Y; Zang Y; Zhang C; Kimball SD; Main AJ; Sun W; Yang Q; Nouraldeen A; Yu XQ; Buxton E; Patel S; Nguyen N; Swaffield J; Powell DR; Wilson A; Liu Q
    J Med Chem; 2008 Jul; 51(13):3684-7. PubMed ID: 18557609
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tryptophan-5-hydroxylase: function and control.
    Gál EM
    Adv Biochem Psychopharmacol; 1974; 11(0):1-11. PubMed ID: 4845686
    [No Abstract]   [Full Text] [Related]  

  • 23. The importance of the gastrointestinal tract in the control of bone mass accrual.
    Karsenty G; Gershon MD
    Gastroenterology; 2011 Aug; 141(2):439-42. PubMed ID: 21699800
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serotonin concentration, synthesis, cell origin, and targets in the rat caput epididymis during sexual maturation and variations associated with adult mating status: morphological and biochemical studies.
    Jiménez-Trejo F; Tapia-Rodríguez M; Queiroz DB; Padilla P; Avellar MC; Manzano PR; Manjarrez-Gutiérrez G; Gutiérrez-Ospina G
    J Androl; 2007; 28(1):136-49. PubMed ID: 16988324
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serotonergic and non-serotonergic targets in the pharmacotherapy of visceral hypersensitivity.
    Bueno L; de Ponti F; Fried M; Kullak-Ublick GA; Kwiatek MA; Pohl D; Quigley EM; Tack J; Talley NJ
    Neurogastroenterol Motil; 2007 Jan; 19(1 Suppl):89-119. PubMed ID: 17280587
    [TBL] [Abstract][Full Text] [Related]  

  • 26. On the role of brain serotonin in expression of genetic predisposition to catalepsy in animal models.
    Popova NK; Kulikov AV
    Am J Med Genet; 1995 Jun; 60(3):214-20. PubMed ID: 7573174
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Review article: The role of serotonergic agents in the treatment of patients with primary chronic constipation.
    Cash BD; Chey WD
    Aliment Pharmacol Ther; 2005 Dec; 22(11-12):1047-60. PubMed ID: 16305718
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tryptophan hydroxylase-2 controls brain serotonin synthesis.
    Zhang X; Beaulieu JM; Sotnikova TD; Gainetdinov RR; Caron MG
    Science; 2004 Jul; 305(5681):217. PubMed ID: 15247473
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 7-Hydroxytryptophan, a novel, specific, cytotoxic agent for carcinoids and other serotonin-producing tumors.
    Walther DJ; Peter JU; Bader M
    Cancer; 2002 Jun; 94(12):3135-40. PubMed ID: 12115345
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis of serotonin by a second tryptophan hydroxylase isoform.
    Walther DJ; Peter JU; Bashammakh S; Hörtnagl H; Voits M; Fink H; Bader M
    Science; 2003 Jan; 299(5603):76. PubMed ID: 12511643
    [No Abstract]   [Full Text] [Related]  

  • 31. Biosynthesis and metabolism of 5-hydroxytryptamine in the central nervous system.
    Kleinrok Z
    Pol J Pharmacol Pharm; 1975 Oct; 27(Suppl):3-12. PubMed ID: 128748
    [No Abstract]   [Full Text] [Related]  

  • 32. Tryptophan hydroxylase and 5-hydroxytryptamine in carcinoids of the gastrointestinal tract.
    Brinck U; Meyer T
    Anticancer Res; 2000; 20(4):2325-8. PubMed ID: 10953292
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The efficacy of osteoquin in treating the postmenopausal and senile forms of osteoporosis].
    Rodionova SS
    Ter Arkh; 1995; 67(10):43-5. PubMed ID: 8779104
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Treatment of osteoporosis with PTH].
    Takeuchi Y
    Clin Calcium; 2014 Jun; 24(6):893-902. PubMed ID: 24870841
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Control of bone remodeling by nervous system. The role of serotonin in the regulation of bone metabolism].
    Inose H
    Clin Calcium; 2010 Dec; 20(12):1850-956. PubMed ID: 21123937
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serotonin and its role in colonic function and in gastrointestinal disorders.
    Costedio MM; Hyman N; Mawe GM
    Dis Colon Rectum; 2007 Mar; 50(3):376-88. PubMed ID: 17195902
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of serotonin-acting agents on the serotonin content of immune cells. A peculiar observation.
    Pállinger E; Csaba G
    Cell Biochem Funct; 2007; 25(5):581-3. PubMed ID: 16615040
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibiting the inhibitor: a new route to bone anabolism.
    Jilka RL
    J Bone Miner Res; 2009 Apr; 24(4):575-7. PubMed ID: 19335216
    [No Abstract]   [Full Text] [Related]  

  • 39. Involvement of striatum serotonergic system in the expression of genetically defined catalepsy.
    Popova NK; Kulikov AV; Avgustinovich DF; Barykina NN
    Ross Fiziol Zh Im I M Sechenova; 1997; 83(5-6):66-79. PubMed ID: 13677667
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Intestinal serotonin and regulation of bone mass].
    Oury F; Karsenty G
    Med Sci (Paris); 2009 May; 25(5):445-6. PubMed ID: 19480820
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.